Royal College of Surgeons in Ireland
Browse
Breakthrough for hepatocellular carcinoma.pdf (155.83 kB)

Breakthrough for hepatocellular carcinoma

Download (155.83 kB)
journal contribution
posted on 2023-08-21, 13:43 authored by Sohrab Zand

Hepatocellular carcinoma (HCC) accounts for 12,000 deaths per year in the United States and over one million deaths per year worldwide, making it the second most lethal malignancy following pancreatic cancer. The five-year survival rate remains at 18%, making early diagnosis and treatment a priority. The therapeutic management of a patient with HCC is determined by staging criteria met at the time of diagnosis. As a result, some patients with advanced disease may not qualify for treatments that are offered to patients with less aggressive disease.

History

Comments

The original article is available at http://www.rcsismj.com/ Part of the RCSIsmj collection: https://doi.org/10.25419/rcsi.c.6798453.v1

Published Citation

Zand S. Breakthrough for hepatocellular carcinoma. RCSIsmj. 2021;14(1):10-11

Publication Date

2021

Department/Unit

  • Undergraduate Research

Publisher

RCSI University of Medicine and Health Sciences

Version

  • Published Version (Version of Record)

Usage metrics

    Royal College of Surgeons in Ireland

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC